Lina Life Insurance Secures Exclusive Rights for 'Minimal Residual Cancer Test Service'... "Care Beyond Cancer Treatment"

On May 13, Lina Life Insurance announced that it has obtained exclusive usage rights for an insurance product that supports monitoring for recurrence and metastatic cancer after a cancer diagnosis.

The insurance rider, "(Non-Participating) Cancer Survivor Support Rider (Minimal Residual Cancer WGS Test Support Type)," which was launched last month as the first of its kind in the industry, provides annual insurance payouts for minimal residual cancer WGS tests or an equivalent amount following a cancer diagnosis. The minimal residual cancer WGS test is used to detect trace amounts of cancer remaining in the body after treatment. By analyzing cancer cell-derived DNA fragments circulating in the blood using whole genome sequencing techniques, it can detect the presence of recurrent, metastatic, or residual cancer.

The (Non-Participating) Cancer Survivor Support Rider (Minimal Residual Cancer WGS Test Support Type) supports up to 11 tests over 10 years after the cancer coverage start date, provided the insured is alive on the anniversary of the initial cancer diagnosis confirmation (twice upon initial diagnosis, and once annually thereafter).

This product has been recognized for its originality as the first to guarantee post-cancer treatment monitoring and for its structure that combines insurance benefits with additional services. Its usefulness has also been highly rated, as it can contribute to improving the quality of life for cancer survivors and reducing social costs by enabling early detection of recurrent or metastatic cancer.

Ki-chul Doh, Director of Customer Solutions at Lina Life Insurance, stated, "This product was developed with the customer's treatment journey in mind, aiming to address not only cancer diagnosis and treatment but also the fear of recurrence or metastasis." He added, "Lina Life Insurance will continue to strive to provide optimal services that help customers manage and address risks across all aspects of their lives."